China Medical System, a Hong Kong-based investment holding company principally engaged in the manufacture, marketing, promotion and sales of pharmaceutical products, completed the acquisition of Luqa Ventures, a retailer of prescription drugs, from Delos Capital, a lower-middle market private equity investment firm. Financial terms were not disclosed. The target company’s product portfolio will be complimentary to the group’s existing dermatology line products and together they will strengthen and bolster the group’s medical aesthetic and skin care product portfolio, providing a significant development opportunity for the group to advance into the field of medical aesthetic solutions and skin care. The group plans to build a comprehensive skin health product matrix consisting of prescription medicines, medical devices and medical aesthetic solutions and skin care products based on which the group will develop its market in the field of skin health.